Friday
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Location: Grand Ballroom East, 3rd Floor
Moderators:Klaus D. Mathias, MD / Marc L. Schermerhorn, MD / Bruce A. Perler, MD, MBA  
SESSION 80 SCHEDULE
7:54 AM - 7:59 AM Carotid Webs: An Important Etiology Of Devastating Strokes Especially In Young Women: How Should They Be Diagnosed And Treated
  Presenter(s):Bruce A. Perler, MD, MBA  
Location: Grand Ballroom East, 3rd Floor
MESH COVERED STENTS
8:00 AM - 8:05 AM Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter
  Presenter(s):Max Amor, MD / D. Christopher C. Metzger, MD   
Location: Grand Ballroom East, 3rd Floor
8:06 AM - 8:11 AM

Power Point Presentation with Synched Audio
When You Can Do All, How To Decide Between CEA, TCAR And TFCAS: Will Mesh Covered Stents Like CGuard Make A Difference
  Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD  
Location: Grand Ballroom East, 3rd Floor
8:12 AM - 8:17 AM Outcome Of TCAR Combined With A Mesh-Covered Stent (CGuard From InspireMD): The Best Of All Worlds: What Is The Proof
  Presenter(s):Ralf R. Kolvenbach, MD  
Location: Grand Ballroom East, 3rd Floor
8:18 AM - 8:23 AM Update On All Trial Results With CGuard And CGuard Prime MicroMesh Covered Stents (InspireMD): Are They Making A Difference And Limitations With Transfemoral/Transradial CAS: Evidence Summary And Long-Term Outcomes
  Presenter(s):Piotr Musialek, MD, DPhil / D. Christopher C. Metzger, MD  / Stefan Mueller-Huelsbeck, MD  
Location: Grand Ballroom East, 3rd Floor
8:24 AM - 8:29 AM US Studies And Status Of The CGuard And CGuard Prime MicroMesh Stents: Can They Be Used In TCAR And Are They Making A Difference
  Presenter(s):Patrick J. Geraghty, MD  
Location: Grand Ballroom East, 3rd Floor
8:30 AM - 8:35 AM Latest Real-World Results Of >2,000 Patients Treated With The Roadsaver (Terumo) Dual-Layer Micromesh Carotid Stent
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
Location: Grand Ballroom East, 3rd Floor
8:36 AM - 8:42 AM Panel Discussion
TCAR RELATED TOPICS
8:42 AM - 8:47 AM Update On Comparative Performance And Risks Of TCAR, Transfemoral CAS (TFCAS) And CEA With > 50K TCAR, 25K TFCAS, And 100K CEA: This Population Based Study Shows That CEA Is Better Than TCAR Which Is Better Than TFCAS
  Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS  
Location: Grand Ballroom East, 3rd Floor
8:48 AM - 8:53 AM Is TCAR Ready To Replace CEA: What About The Clinical Results To Date: What About The Impact Of Clever Marketing: How Will We Find Out
  Presenter(s):Bruce A. Perler, MD, MBA  
Location: Grand Ballroom East, 3rd Floor
8:54 AM - 8:59 AM DEBATE: CEA Versus TCAR In A Single Center Propensity Matched Study: The Outcomes Of The Two Treatments Are Comparable At 30 Days But TCAR Has A Higher Mortality At 2 Years
  Presenter(s):Ali F. AbuRahma, MD / Zach AbuRahma, DO  
Location: Grand Ballroom East, 3rd Floor
9:00 AM - 9:05 AM DEBATE: Not So: TCAR Like TFCAS Has Durable Effectiveness Without Increased Mortality At 2 Years And Beyond
  Presenter(s):Sumaira Macdonald, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
9:06 AM - 9:11 AM Favorable 30-Day Results Of TCAR In Good Risk Symptomatic And Asymptomatic Patients: Late Breaking Trial Results From ROADSTER 3 Shows That The Stroke, Death And MI Rates Are Lower Than In High Risk Patients
  Presenter(s):Marc L. Schermerhorn, MD  
Location: Grand Ballroom East, 3rd Floor
9:12 AM - 9:17 AM TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why TCAR Should Be The Procedure Of Choice In These Conditions
  Presenter(s):Peter A. Schneider, MD  
Location: Grand Ballroom East, 3rd Floor
9:18 AM - 9:23 AM Panel Discussion
9:24 AM - 9:34 AM Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 80
previous next